Biopharmaceutics stands at the forefront of pharmaceutical innovation, focusing on the study of drug substances and their interaction within the human body. Unlike traditional pharmaceuticals, biopharmaceuticals are derived from living organisms or biological systems, harnessing the power of biotechnology for therapeutic advancements.
These complex substances offer targeted and personalized treatment, paving the way for precision medicine. Biopharmaceutics plays a crucial role in understanding how drugs are absorbed, distributed, metabolized, and excreted, shedding light on their efficacy and safety profiles. The emphasis on biopharmaceutics has revolutionized drug development, leading to the creation of biologics, monoclonal antibodies, and gene therapies that address previously challenging medical conditions.
In the realm of drug substances, biopharmaceutics opens avenues for optimizing formulations, ensuring optimal drug delivery, and tailoring treatments to individual patient needs. As we delve deeper into the intricate landscape of biopharmaceutics, the potential for groundbreaking therapies and enhanced patient outcomes continues to expand, promising a new era in pharmaceutical science.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia